Published in Oncology Business Week, February 14th, 2010
"These data are important for assessing impact of adherence on BABY HUG trial outcome and defining impact of SES on adherence. Each subject's median study medication...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.